Modeling the Value for Money of Changing Clinical Practice Change A Stochastic Application in Diabetes Care

被引:24
作者
Hoomans, Ties [1 ,5 ]
Abrams, Keith R. [2 ]
Ament, Andre J. H. A. [1 ]
Evers, Silvia M. A. A. [1 ]
Severens, Johan L. [1 ,3 ,4 ]
机构
[1] Maastricht Univ, Dept Hlth Org Policy & Econ, NL-6200 MD Maastricht, Netherlands
[2] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England
[3] Univ Hosp Maastricht, Dept Clin Epidemiol, Maastricht, Netherlands
[4] Univ Hosp Maastricht, MTA, Maastricht, Netherlands
[5] Univ Glasgow, Sect Publ Hlth & Hlth Policy, Glasgow G12 8QQ, Lanark, Scotland
关键词
health economics; implementation research; decision analysis; stochastic models; decision making; COST-EFFECTIVENESS; DECISION-MAKING; GUIDELINE IMPLEMENTATION; ACCEPTABILITY CURVES; ECONOMIC EVALUATIONS; QUALITY; UNCERTAINTY; INFORMATION; MORTALITY; INCREASE;
D O I
10.1097/MLR.0b013e31819e1f2b
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Decision making about resource allocation for guideline implementation to change clinical practice is inevitably undertaken in a context of uncertainty surrounding the cost-effectiveness of both clinical guidelines and implementation strategies. Adopting a total net benefit approach, a model was recently developed to overcome problems with the use of combined ratio statistics when analyzing decision uncertainty. Objective: To demonstrate the stochastic application of the model for informing decision making about the adoption of an audit and feedback strategy for implementing a guideline recommending intensive blood glucose control in type 2 diabetes in primary care in the Netherlands. Methods: An integrated Bayesian approach to decision modeling and evidence synthesis is adopted, using Markov Chain Monte Carlo simulation in WinBUGs. Data on model parameters is gathered from various sources, with effectiveness of implementation being estimated using pooled, random-effects meta-analysis. Decision uncertainty is illustrated using cost-effectiveness acceptability curves and frontier. Results: Decisions about whether to adopt intensified glycemic control and whether to adopt audit and feedback alter for the maximum values that decision makers are willing to pay for health gain. Through simultaneously incorporating uncertain economic evidence on both guidance and implementation strategy, the cost-effectiveness acceptability curves and cost-effectiveness acceptability frontier show an increase in decision uncertainty concerning guideline implementation. Conclusions: The stochastic application in diabetes care demonstrates that the model provides a simple and useful tool for quantifying and exploring the (combined) uncertainty associated with decision making about adopting guidelines and implementation strategies and, therefore, for informing decisions about efficient resource allocation to change clinical practice. Key Words: health economics, implementation research, decision analysis, stochastic models, decision making
引用
收藏
页码:1053 / 1061
页数:9
相关论文
共 50 条
[1]   Evidence synthesis, parameter correlation and probabilistic sensitivity analysis [J].
Ades, AE ;
Claxton, K ;
Sculpher, M .
HEALTH ECONOMICS, 2006, 15 (04) :373-381
[2]   Bayesian methods for evidence synthesis in cost-effectiveness analysis [J].
Ades, AE ;
Sculpher, M ;
Sutton, A ;
Abrams, K ;
Cooper, N ;
Welton, N ;
Lu, GB .
PHARMACOECONOMICS, 2006, 24 (01) :1-19
[3]  
[Anonymous], 1998, BMJ, V317, P703, DOI DOI 10.1136/BMJ.317.7160.703
[4]  
[Anonymous], NAT KOMP VOLKSG
[5]  
Bouma M, 2006, Ned Tijdschr Geneeskd, V150, P2251
[6]   Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72) [J].
Clarke, PM ;
Gray, AM ;
Briggs, A ;
Stevens, RJ ;
Matthews, DR ;
Holman, RR .
DIABETOLOGIA, 2005, 48 (05) :868-877
[7]  
Claxton K, 2006, ELGAR ORIG REF, P514
[8]  
Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5
[9]   Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach [J].
Cooper, NJ ;
Sutton, AJ ;
Abrams, KR ;
Turner, D ;
Wailoo, A .
HEALTH ECONOMICS, 2004, 13 (03) :203-226
[10]   Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis [J].
Dijkstra, RF ;
Niessen, LW ;
Braspenning, JCC ;
Adang, E ;
Grol, RTPM .
DIABETIC MEDICINE, 2006, 23 (02) :164-170